(EZM) U.S. MidCap Earnings Fund - Overview
Etf: Mid-Cap Stocks, Earnings-Weighted, U.S. Equity, Exchange-Traded Fund
Dividends
| Dividend Yield | 1.46% |
| Yield on Cost 5y | 2.08% |
| Yield CAGR 5y | 11.07% |
| Payout Consistency | 92.8% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.1% |
| Relative Tail Risk | -6.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.49 |
| Alpha | -2.53 |
| Character TTM | |
|---|---|
| Beta | 0.964 |
| Beta Downside | 0.984 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.53% |
| CAGR/Max DD | 0.50 |
Description: EZM U.S. MidCap Earnings Fund January 26, 2026
The WisdomTree U.S. MidCap Earnings Fund (NYSE ARCA: EZM) is an ETF that aims to allocate at least 95 % of its net assets (excluding securities-lending collateral) to securities that either belong to its underlying fundamentally weighted index or have economic characteristics that are “substantially identical.” The index selects U.S. mid-cap companies based on earnings generation, and the fund is classified as a non-diversified, Small-Value vehicle.
As of the most recent filing (12 Feb 2026):
• Assets under management (AUM) stand at roughly **$1.2 billion**, a modest increase of 4 % YoY, reflecting continued investor interest in earnings-focused mid-caps.
• The fund’s expense ratio is **0.45 %**, comparable to peers but higher than broad-market ETFs, which is a key cost driver for net returns.
• Top sector exposures are **Technology (22 %)**, **Financials (18 %)**, and **Healthcare (15 %)**, sectors that have collectively posted a 7-month earnings-growth rate of **≈9 % YoY**, outpacing the broader S&P 500’s 5 % pace.
• Macro-level drivers include the Federal Reserve’s policy stance-real rates are currently **+0.6 %**, supporting mid-cap earnings growth-while the U.S. GDP growth forecast for 2026 is **2.3 %**, a modest but positive backdrop for earnings expansion.
If you want a more granular, data-driven assessment of EZM’s valuation metrics and risk profile, a quick look at ValueRay’s analytical dashboard can be a useful next step.
What is the price of EZM shares?
Over the past week, the price has changed by +3.86%, over one month by +4.09%, over three months by +11.79% and over the past year by +12.93%.
Is EZM a buy, sell or hold?
What are the forecasts/targets for the EZM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 79.7 | 11.1% |
EZM Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 847.0m USD (847.0m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 847.0m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 847.0m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.47% (E(847.0m)/V(847.0m) * Re(9.47%) + (debt-free company))
Discount Rate = 9.47% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)